Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117817282 | 11781728 | 2 | F | 20150923 | 20160131 | 20151126 | 20160701 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-080431 | BRISTOL MYERS SQUIBB | 36.00 | YR | F | Y | 0.00000 | 20160701 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117817282 | 11781728 | 1 | PS | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | 1 | Oral | 300 MG, QD | 21567 | 300 | MG | QD | |||||||
| 117817282 | 11781728 | 2 | SS | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | 1 | 21567 | ||||||||||||
| 117817282 | 11781728 | 3 | SS | ABACAVIR + LAMIVUDIN | ABACAVIRLAMIVUDINE | 1 | Oral | 1 DF, QD | 0 | 1 | DF | QD | |||||||
| 117817282 | 11781728 | 4 | SS | ABACAVIR + LAMIVUDIN | ABACAVIRLAMIVUDINE | 1 | 0 | ||||||||||||
| 117817282 | 11781728 | 5 | SS | TRIUMEQ | ABACAVIR SULFATEDOLUTEGRAVIR SODIUMLAMIVUDINE | 1 | Oral | 1 DF, QD | Y | 0 | 1 | DF | QD | ||||||
| 117817282 | 11781728 | 6 | SS | TRIUMEQ | ABACAVIR SULFATEDOLUTEGRAVIR SODIUMLAMIVUDINE | 1 | Y | 0 | |||||||||||
| 117817282 | 11781728 | 7 | SS | NORVIR | RITONAVIR | 1 | Oral | 100 MG, QD | 0 | 100 | MG | QD | |||||||
| 117817282 | 11781728 | 8 | SS | NORVIR | RITONAVIR | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117817282 | 11781728 | 1 | HIV infection |
| 117817282 | 11781728 | 2 | Hepatitis C |
| 117817282 | 11781728 | 3 | HIV infection |
| 117817282 | 11781728 | 4 | Hepatitis C |
| 117817282 | 11781728 | 5 | HIV infection |
| 117817282 | 11781728 | 6 | Hepatitis C |
| 117817282 | 11781728 | 7 | HIV infection |
| 117817282 | 11781728 | 8 | Hepatitis C |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117817282 | 11781728 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117817282 | 11781728 | Abortion spontaneous | |
| 117817282 | 11781728 | Maternal exposure during pregnancy | |
| 117817282 | 11781728 | Vaginal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117817282 | 11781728 | 1 | 20150729 | 0 | ||
| 117817282 | 11781728 | 5 | 20150729 | 0 | ||
| 117817282 | 11781728 | 7 | 20150729 | 0 |